Cargando…

Comprehensive investigating of MMR gene in hepatocellular carcinoma with chronic hepatitis B virus infection in Han Chinese population

Hepatocellular carcinoma associated with chronic hepatitis B virus infection seriously affects human health. Present studies suggest that genetic susceptibility plays an important role in the mechanism of cancer development. Therefore, this study focused on single nucleotide polymorphisms (SNPs) of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Ning, Jin, Ao, Sun, Yitong, Jin, Yiyao, Sun, Yucheng, Xiao, Qian, Sha, XuanYi, Yu, Fengxue, Yang, Lei, Liu, Wenxuan, Gao, Xia, Zhang, Xiaolin, Li, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079871/ https://www.ncbi.nlm.nih.gov/pubmed/37035153 http://dx.doi.org/10.3389/fonc.2023.1124459

Ejemplares similares

Comprehensive investigating of mismatch repair genes (MMR) polymorphisms in participants with chronic hepatitis B virus infection
por: Ma, Ning, et al.
Publicado: (2023)

Oxidative Stress-Related Gene Polymorphisms Are Associated With Hepatitis B Virus-Induced Liver Disease in the Northern Chinese Han Population
por: Ma, Ning, et al.
Publicado: (2020)

Serum Tumor Markers Combined With Clinicopathological Characteristics for Predicting MMR and KRAS Status in 2279 Chinese Colorectal Cancer Patients: A Retrospective Analysis
por: Zhao, Ning, et al.
Publicado: (2021)

A Case–Control Study of ADCY9 Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in the Chinese Han Population
por: Chao, Xu, et al.
Publicado: (2020)

Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy
por: Zhang, Yuguo, et al.
Publicado: (2022)

High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer
por: Mohamed, Amr, et al.
Publicado: (2021)

Case report: Bullous pemphigoid associated with sintilimab therapy for pMMR/MSS colorectal cancer
por: Wang, Ting, et al.
Publicado: (2023)

Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma
por: Ma, Yu-Ting, et al.
Publicado: (2022)

Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy
por: Wu, Hui, et al.
Publicado: (2023)

LRRC3B Polymorphisms Contributed to Breast Cancer Susceptibility in Chinese Han Population
por: Wang, Yuxin
Publicado: (2021)

The polymorphisms of ANXA6 influence head and neck cancer susceptibility in the Chinese Han population
por: Xiong, Weihong, et al.
Publicado: (2023)

Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma
por: Ma, Yu-Ting, et al.
Publicado: (2023)

Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
por: Oliveira, André F., et al.
Publicado: (2019)

Comprehensive analysis of lncRNA-mediated ceRNA networkfor hepatocellular carcinoma
por: Chen, Weiqing, et al.
Publicado: (2022)

Analysis of Immune Landscape Reveals Prognostic Significance of Cytotoxic CD4(+) T Cells in the Central Region of pMMR CRC
por: Qi, Jingwen, et al.
Publicado: (2021)

Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer
por: Riedinger, Courtney J., et al.
Publicado: (2023)

Differences in the Association Between Modifiable Lifestyle Factors and Gastric Precancerous Lesions Among Mongolians and Han Chinese
por: Wang, Weiwei, et al.
Publicado: (2022)

Comprehensive pan-cancer analysis of PTGES3 and its prognostic role in hepatocellular carcinoma
por: Wang, Han, et al.
Publicado: (2023)

Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances
por: Zhang, Yucheng, et al.
Publicado: (2021)

Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN
por: Guo, Xi, et al.
Publicado: (2022)

The Alteration of T-Cell Heterogeneity and PD-L1 Colocalization During dMMR Colorectal Cancer Progression Defined by Multiplex Immunohistochemistry
por: Yan, Hongkai, et al.
Publicado: (2022)

PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report
por: Yang, Jiabao, et al.
Publicado: (2023)

Immune Checkpoint Blockade in Chinese Patients With Hepatocellular Carcinoma: Characteristics and Particularity
por: Wu, Yaoqiang, et al.
Publicado: (2022)

Single Nucleotide Polymorphisms of EXOC1, BCL2, CCAT2, and CARD8 Genes and Susceptibility to Cervical Cancer in the Northern Chinese Han Population
por: Feng, Yanan, et al.
Publicado: (2022)

A comprehensive comparison of circulating tumor cells and breast imaging modalities as screening tools for breast cancer in Chinese women
por: Shao, Xuan, et al.
Publicado: (2022)

Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report
por: Zhong, Liting, et al.
Publicado: (2022)

Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients
por: Huang, Jiwei, et al.
Publicado: (2021)

The Rare Variant rs35356162 in UHRF1BP1 Increases Bladder Cancer Risk in Han Chinese Population
por: Wu, Junlong, et al.
Publicado: (2020)

Comprehensive Characterization of Immunological Profiles and Clinical Significance in Hepatocellular Carcinoma
por: Tao, Ping, et al.
Publicado: (2021)

Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma
por: Wang, Yongkang, et al.
Publicado: (2021)

Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma
por: Dai, Weiyu, et al.
Publicado: (2021)

Improving health literacy with mumps, measles and rubella (MMR) vaccination: comparison of the readability of MMR patient-facing literature and MMR scientific abstracts
por: Downey, Tina, et al.
Publicado: (2022)

Prognostic significance of nomograms integrating IL‐37 expression, neutrophil level, and MMR status in patients with colorectal cancer
por: Zhu, Bing, et al.
Publicado: (2018)

Lenvatinib as second-line treatment in patients with unresectable hepatocellular carcinoma: A retrospective analysis
por: Qin, He-nan, et al.
Publicado: (2022)

Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China
por: Gou, Miaomiao, et al.
Publicado: (2022)

Squamous cell carcinoma of ascending colon with pMMR/MSS showed a partial response to PD-1 blockade combined with chemotherapy: A case report
por: Liu, Yan, et al.
Publicado: (2023)

Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma
por: Cai, Qun, et al.
Publicado: (2022)

PPARG rs3856806 C>T Polymorphism Increased the Risk of Colorectal Cancer: A Case-Control Study in Eastern Chinese Han Population
por: Lin, Jing, et al.
Publicado: (2019)

Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report
por: Varnier, Romain, et al.
Publicado: (2021)

Rectosigmoid-Junction Squamous Cell Carcinoma With pMMR/MSS Achieved a Partial Response Following PD-1 Blockade Combined With Chemotherapy: A Case Report
por: He, Yanxin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5slmbmnovppku8iabv1baoub3o